share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kearney Terrence C

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kearney Terrence C

福泰制药 | 4:持股变动声明-董事 Kearney Terrence C
美股SEC公告 ·  05/03 16:19

Moomoo AI 已提取核心信息

Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Vertex Pharmicals Inc.(VRTX)报告了一笔涉及该公司相关举报人特伦斯·科尔尼的交易。该交易于2024年1月5日进行,没有具体说明科尔尼与发行人的关系。公告中没有披露有关股票性质、交易股票数量、交易价格以及交易后由此产生的所有权的详细信息。
Vertex Pharmicals Inc.(VRTX)报告了一笔涉及该公司相关举报人特伦斯·科尔尼的交易。该交易于2024年1月5日进行,没有具体说明科尔尼与发行人的关系。公告中没有披露有关股票性质、交易股票数量、交易价格以及交易后由此产生的所有权的详细信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息